{"title":"Comment encadrer les pratiques hors AMM dans les maladies rares : autour d’un cas d’hémophilie A acquise prise en charge par émicizumab","authors":"T. Mélin, L. Tourvieilhe, V. Chamouard","doi":"10.1016/j.phacli.2024.04.302","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508818,"journal":{"name":"Le Pharmacien Clinicien","volume":"23 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Le Pharmacien Clinicien","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.phacli.2024.04.302","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
